Sagimet Biosciences Inc. - Series A · NASDAQ:SGMT
Balyasny Asset Management L.P. reported a 5.93% stake in Sagimet Biosciences Inc. - Series A (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Balyasny Asset Management L.P. reported a 5.93% stake in Sagimet Biosciences Inc. - Series A, 3,626,113 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 5.93%
- Shares
- 3,626,113
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 5.93% | 3,626,113 |
| BAM GP LLC | 5.93% | 3,626,113 |
| Balyasny Asset Management Holdings LP | 5.93% | 3,626,113 |
| Dames GP LLC | 5.93% | 3,626,113 |
| Dmitry Balyasny | 5.93% | 3,626,113 |
Source
Related
- Sagimet Biosciences Inc. - Series A
- Balyasny Asset Management L.P.
- Sagimet Biosciences Inc. - Series A shareholders
- Schedule 13G · Commodore Capital LP · Oct 7, 2026
- Form 4 · Kemble George · Aug 17, 2026
- Form 4 · Kemble George · Aug 12, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Happel David · Jul 22, 2026